Australia's most trusted
source of pharma news
Sunday, 22 June 2025
Posted 16 June 2025 PM
Sanofi's voluntary admission that it provided Olympics tickets to some patients has resulted in a ruling that it brought discredit on the industry.
The French pharma was a premium sponsor of the 2024 Olympic and Paralympic Games in Paris, which it used to draw a parallel between sporting and scientific success. As part of the sponsorship Sanofi received some tickets to the Olympics and Paralympics, some of which made their way to local employees.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.